{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:57:13Z","timestamp":1786993033154,"version":"build-2736575974"},"reference-count":51,"publisher":"Stanford University Press","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100030687","name":"Nutrition Obesity Research Center, University of Washington","doi-asserted-by":"publisher","award":["P30DK035816"],"award-info":[{"award-number":["P30DK035816"]}],"id":[{"id":"10.13039\/100030687","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008342","name":"Diabetes Research Center, University of Washington","doi-asserted-by":"publisher","award":["P30DK017047"],"award-info":[{"award-number":["P30DK017047"]}],"id":[{"id":"10.13039\/100008342","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01DK121289 ANH"],"award-info":[{"award-number":["U01DK121289 ANH"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01DK137097 ANH\/MJM"],"award-info":[{"award-number":["U01DK137097 ANH\/MJM"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Mass Spectrometry and Advances in the Clinical Lab"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jmsacl.2025.04.002","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T03:12:04Z","timestamp":1744341124000},"page":"37-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Quantification of glucagon and oxyntomodulin by protein precipitation-immunoaffinity enrichment-LC-MS\/MS"],"prefix":"10.21627","volume":"36","author":[{"given":"Jessica O.","family":"Becker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara K.","family":"Shijo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7814-3189","authenticated-orcid":false,"given":"Huu-Hien","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina L.","family":"Forrest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"MacCoss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle A.","family":"Emrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisha","family":"Goonatilleke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6449-0243","authenticated-orcid":false,"given":"Andrew N.","family":"Hoofnagle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4811","reference":[{"key":"10.1016\/j.jmsacl.2025.04.002_b0005","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1152\/physrev.00013.2014","article-title":"Physiology of proglucagon peptides: role of glucagon and GLP-1 in health and disease","volume":"95","author":"Sandoval","year":"2015","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jmsacl.2025.04.002_b0010","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.3390\/ijms20133314","article-title":"Glucagon receptor signaling and glucagon resistance","volume":"20","author":"Janah","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jmsacl.2025.04.002_b0015","doi-asserted-by":"crossref","first-page":"E671","DOI":"10.1152\/ajpendo.00492.2002","article-title":"Glucagon and regulation of glucose metabolism","volume":"284","author":"Jiang","year":"2003","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.jmsacl.2025.04.002_b0020","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2337\/db23-0201","article-title":"High doses of exogenous glucagon stimulate insulin secretion and reduce insulin clearance in healthy humans","volume":"73","author":"Gray","year":"2024","journal-title":"Diabetes."},{"key":"10.1016\/j.jmsacl.2025.04.002_b0025","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.2337\/db17-1331","article-title":"Native oxyntomodulin has significant glucoregulatory effects independent of weight loss in obese humans with and without type 2 diabetes","volume":"67","author":"Shankar","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.jmsacl.2025.04.002_b0030","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.molmet.2013.12.001","article-title":"Action and therapeutic potential of oxyntomodulin","volume":"3","author":"Pocai","year":"2014","journal-title":"Mol. Metab."},{"key":"10.1016\/j.jmsacl.2025.04.002_b0035","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.689678","article-title":"Proglucagon-derived peptides as therapeutics","volume":"12","author":"Lafferty","year":"2021","journal-title":"Front Endocrinol (Lausanne)."},{"key":"10.1016\/j.jmsacl.2025.04.002_b0040","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1530\/EJE-13-0941","article-title":"Specificity and sensitivity of commercially available assays for glucagon and oxyntomodulin measurement in humans","volume":"170","author":"Bak","year":"2014","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jmsacl.2025.04.002_b0045","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/jdi.13986","article-title":"A newly developed glucagon sandwich ELISA is useful for more accurate glucagon evaluation than the currently used sandwich ELISA in subjects with elevated plasma proglucagon-derived peptide levels","volume":"14","author":"Kobayashi","year":"2023","journal-title":"J. Diabetes Investig."},{"key":"10.1016\/j.jmsacl.2025.04.002_b0050","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.4155\/bio-2022-0084","article-title":"Development of a selective, sensitive and robust oxyntomodulin dual monoclonal antibody immunoassay","volume":"14","author":"Umberger","year":"2022","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jmsacl.2025.04.002_b0055","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1007\/s00125-014-3283-z","article-title":"Hyperglucagonaemia analysed by glucagon sandwich ELISA: nonspecific interference or truly elevated levels?","volume":"57","author":"Wewer Albrechtsen","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.jmsacl.2025.04.002_b0060","doi-asserted-by":"crossref","DOI":"10.3390\/biom12030466","article-title":"Assessment of two different glucagon assays in healthy individuals and type 1 and type 2 diabetes patients","volume":"12","author":"Brunner","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.jmsacl.2025.04.002_b0065","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1210\/jc.2017-00928","article-title":"Impact of the glucagon assay when assessing the effect of chronic liraglutide therapy on glucagon secretion","volume":"102","author":"Kramer","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jmsacl.2025.04.002_b0070","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8352957","article-title":"Inability of some commercial assays to measure suppression of glucagon secretion","volume":"2016","author":"Wewer Albrechtsen","year":"2016","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.jmsacl.2025.04.002_b0075","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1159\/000518027","article-title":"Measurement of plasma glucagon levels using mass spectrometry in patients with type 2 diabetes on maintenance hemodialysis","volume":"46","author":"Yoshizawa","year":"2021","journal-title":"Kidney Blood Press. Res."},{"key":"10.1016\/j.jmsacl.2025.04.002_b0080","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jim.2009.06.003","article-title":"The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry","volume":"347","author":"Hoofnagle","year":"2009","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jmsacl.2025.04.002_b0085","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.cca.2020.11.004","article-title":"Development and validation of a fast and reliable method for the quantification of glucagon by liquid chromatography and tandem mass spectrometry","volume":"512","author":"Farre-Segura","year":"2021","journal-title":"Clinica Chimica Acta; Int. J. Clin Chem."},{"key":"10.1016\/j.jmsacl.2025.04.002_b0090","doi-asserted-by":"crossref","first-page":"733","DOI":"10.4155\/bio-2017-0021","article-title":"Development of a UHPLC-MS\/MS (SRM) method for the quantitation of endogenous glucagon and dosed GLP-1 from human plasma","volume":"9","author":"Howard","year":"2017","journal-title":"Bioanalysis."},{"key":"10.1016\/j.jmsacl.2025.04.002_b0095","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1210\/js.2018-00142","article-title":"Postprandial plasma glucagon kinetics in type 2 diabetes mellitus: comparison of immunoassay and mass spectrometry","volume":"3","author":"Katahira","year":"2019","journal-title":"J. Endocr. Soc."},{"key":"10.1016\/j.jmsacl.2025.04.002_b0100","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1373\/clinchem.2015.244251","article-title":"Multiplexed quantification of proglucagon-derived peptides by immunoaffinity enrichment and tandem mass spectrometry after a meal tolerance test","volume":"62","author":"Lee","year":"2016","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jmsacl.2025.04.002_b0105","doi-asserted-by":"crossref","first-page":"5911","DOI":"10.1007\/s00216-017-0534-0","article-title":"Accurate analytical method for human plasma glucagon levels using liquid chromatography-high resolution mass spectrometry: comparison with commercially available immunoassays","volume":"409","author":"Miyachi","year":"2017","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jmsacl.2025.04.002_b0110","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12014-022-09344-2","article-title":"(13)C(15)N: glucagon-based novel isotope dilution mass spectrometry method for measurement of glucagon metabolism in humans","volume":"19","author":"Renuse","year":"2022","journal-title":"Clin. Proteomics."},{"key":"10.1016\/j.jmsacl.2025.04.002_b0115","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20215416","article-title":"Methods and guidelines for measurement of glucagon in plasma","volume":"20","author":"Holst","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jmsacl.2025.04.002_b0120","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1515\/CCLM.2004.138","article-title":"Metrological traceability of calibration in the estimation and use of common medical decision-making criteria","volume":"42","author":"Thienpont","year":"2004","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.jmsacl.2025.04.002_b0125","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-1-61779-445-2_3","article-title":"Isotope dilution liquid chromatography-tandem mass spectrometry for quantitative amino acid analysis","volume":"828","author":"Bunk","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jmsacl.2025.04.002_b0130","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/978-1-4939-9639-1_12","article-title":"Isotope dilution liquid chromatography-tandem mass spectrometry for quantitative amino acid analysis","volume":"2030","author":"Bunk","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jmsacl.2025.04.002_b0135","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/bioinformatics\/btq054","article-title":"Skyline: an open source document editor for creating and analyzing targeted proteomics experiments","volume":"26","author":"MacLean","year":"2010","journal-title":"Bioinformatics."},{"key":"10.1016\/j.jmsacl.2025.04.002_b0140","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/mas.21540","article-title":"The skyline ecosystem: informatics for quantitative mass spectrometry proteomics","volume":"39","author":"Pino","year":"2020","journal-title":"Mass Spectrom. Rev."},{"key":"10.1016\/j.jmsacl.2025.04.002_b0145","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1074\/mcp.RA117.000543","article-title":"Panorama public: a public repository for quantitative data sets processed in skyline","volume":"17","author":"Sharma","year":"2018","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.jmsacl.2025.04.002_b0150","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1373\/clinchem.2013.208538","article-title":"Interlaboratory agreement of insulin-like growth factor 1 concentrations measured by mass spectrometry","volume":"60","author":"Cox","year":"2014","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jmsacl.2025.04.002_b0155","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jmsacl.2022.06.003","article-title":"Multiplexed quantification of insulin and C-peptide by LC-MS\/MS without the use of antibodies","volume":"25","author":"Foulon","year":"2022","journal-title":"J. Mass Spectrom. Adv. Clin. Lab."},{"key":"10.1016\/j.jmsacl.2025.04.002_b0160","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/clinchem\/hvac119","article-title":"A targeted liquid chromatography-tandem mass spectrometry method for simultaneous quantification of peptides from the carboxyl-terminal region of type III procollagen, biomarkers of collagen turnover","volume":"68","author":"Huynh","year":"2022","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jmsacl.2025.04.002_b0165","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/clinchem\/hvad056","article-title":"Metrologically traceable quantification of 3 apolipoprotein E isoforms in cerebrospinal fluid","volume":"69","author":"Huynh","year":"2023","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jmsacl.2025.04.002_b0170","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/clinchem\/hvaa043","article-title":"Inter-laboratory agreement of insulin-like growth factor 1 concentrations measured intact by mass spectrometry","volume":"66","author":"Moncrieffe","year":"2020","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jmsacl.2025.04.002_b0175","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1373\/clinchem.2014.224840","article-title":"From lost in translation to paradise found: enabling protein biomarker method transfer by mass spectrometry","volume":"60","author":"Grant","year":"2014","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jmsacl.2025.04.002_b0180","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0009-8981(84)90245-6","article-title":"Evaluation of a sensitive and specific radioimmunoassay for pancreatic glucagon in human plasma and its clinical application","volume":"136","author":"Borghi","year":"1984","journal-title":"Clinica Chimica Acta; Int. J. Clin. Chem."},{"key":"10.1016\/j.jmsacl.2025.04.002_b0185","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.2337\/dc09-0798","article-title":"Beta-cell-mediated signaling predominates over direct alpha-cell signaling in the regulation of glucagon secretion in humans","volume":"32","author":"Cooperberg","year":"2009","journal-title":"Diabetes Care."},{"key":"10.1016\/j.jmsacl.2025.04.002_b0190","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/j.1464-5491.2007.02116.x","article-title":"Plasma glucagon decreases during night-time sleep in type 1 diabetic patients and healthy control subjects","volume":"24","author":"Jauch-Chara","year":"2007","journal-title":"Diabet. Med."},{"key":"10.1016\/j.jmsacl.2025.04.002_b0195","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1046\/j.1365-2796.2002.01043.x","article-title":"Residual insulin secretion is not coupled to a maintained glucagon response to hypoglycaemia in long-term type 1 diabetes","volume":"252","author":"Sjoberg","year":"2002","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.jmsacl.2025.04.002_b0200","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1172\/JCI106297","article-title":"Studies of pancreatic alpha cell function in normal and diabetic subjects","volume":"49","author":"Unger","year":"1970","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jmsacl.2025.04.002_b0205","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/483531a","article-title":"Drug development: raise standards for preclinical cancer research","volume":"483","author":"Begley","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jmsacl.2025.04.002_b0210","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nrd3439-c1","article-title":"Believe it or not: how much can we rely on published data on potential drug targets?","volume":"10","author":"Prinz","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jmsacl.2025.04.002_b0215","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1515\/cclm-2013-0015","article-title":"Commercial immunoassays in biomarkers studies: researchers beware!","volume":"51","author":"Rifai","year":"2013","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.jmsacl.2025.04.002_b0220","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqab150","article-title":"Preproglucagon products and their respective roles regulating insulin secretion","volume":"162","author":"Bethea","year":"2021","journal-title":"Endocrinology"},{"key":"10.1016\/j.jmsacl.2025.04.002_b0225","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1373\/clinchem.2015.250563","article-title":"Recommendations for the generation, quantification, storage, and handling of peptides used for mass spectrometry-based assays","volume":"62","author":"Hoofnagle","year":"2016","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jmsacl.2025.04.002_b0230","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/prca.200780174","article-title":"The interface between biomarker discovery and clinical validation: the tar pit of the protein biomarker pipeline","volume":"2","author":"Paulovich","year":"2008","journal-title":"Proteomics Clin. Appl."},{"key":"10.1016\/j.jmsacl.2025.04.002_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2023.123904","article-title":"Tutorial review for peptide assays: an ounce of pre-analytics is worth a pound of cure","volume":"1229","author":"Maurer","year":"2023","journal-title":"J. Chromatogr. B, Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jmsacl.2025.04.002_b0240","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/0004563216675648","article-title":"The preanalytical stability of glucagon as measured by liquid chromatography tandem mass spectrometry and two commercially available immunoassays","volume":"54","author":"Cegla","year":"2017","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.jmsacl.2025.04.002_b0245","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1210\/en.2011-1499","article-title":"Minireview: glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes","volume":"153","author":"Cryer","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.jmsacl.2025.04.002_b0250","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2337\/diacare.11.8.643","article-title":"Glucagon responses to hypoglycemia in children and adolescents with IDDM","volume":"11","author":"Singer-Granick","year":"1988","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jmsacl.2025.04.002_b0255","doi-asserted-by":"crossref","DOI":"10.1002\/dta.3814","article-title":"A novel high-throughput immunoaffinity LC-MS\/MS assay for P-III-NP and other fragments of type III procollagen in human serum","author":"Huynh","year":"2024","journal-title":"Drug Test. Anal."}],"container-title":["Journal of Mass Spectrometry and Advances in the Clinical Lab"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667145X25000100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667145X25000100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T07:22:50Z","timestamp":1767770570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667145X25000100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":51,"alternative-id":["S2667145X25000100"],"URL":"https:\/\/doi.org\/10.1016\/j.jmsacl.2025.04.002","relation":{},"ISSN":["2667-145X"],"issn-type":[{"value":"2667-145X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantification of glucagon and oxyntomodulin by protein precipitation-immunoaffinity enrichment-LC-MS\/MS","name":"articletitle","label":"Article Title"},{"value":"Journal of Mass Spectrometry and Advances in the Clinical Lab","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmsacl.2025.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 THE AUTHORS. Publishing services by ELSEVIER B.V. on behalf of MSACL.","name":"copyright","label":"Copyright"}]}}